Advances:
- Abercrombie & Fitch (ANF) +11.4%. 4Q earnings surprise to the upside.
- AeroVironment (AVAV) +11%. Annual guidance beats expectations.
- Ambarella (AMBA) +9.5%. 4Q earnings better than expected, outlook better than feared.
- J. Jill (JILL) +7.6%. 4Q earnings better than expected.
- Aon (AON) +6.1%. Company confirms it won't pursue deal with Willis Towers Watson.
- Dollar Tree (DLTR) +3.9%. 4Q comparable store sales beat expectations, 2019 guidance in line.
- BJ's Wholesale Club (BJ) +3.6%. 4Q revenue and EBITDA much better than expected.
- Mylan (MYL) +2.6%. Upgrade at Morgan Stanley.
Declines:
- Thor Industries (THO) -6.4%. 2Q sales disappoint.
- United Natural Foods (UNFI) -5.4%. 2Q GAAP earnings and EBITDA disappoint.
- Alnylam Pharmaceuticals (ALNY) -5.1%. Safety concerns related to liver treatment "Givosiran."
- CymaBay Therapeutics (CBAY) -5.3%. Offering 8 million shares at $12.50 per share.
- Willis Towers Watson (WLTW) -5.2%. Aon confirms it's not pursuing an acquisition.
- Sarepta Therapeutics (SRPT) -4.1%. Offering 2.6 million shares at $144 per share.
- Horizon Pharma (HZNP) -3.7%. Department of Justice is investigating payments to pharmacy benefit managers.
- General Electric (GE) -3.6%. Company forecast negative free cash flow for 2019.
- TripAdvisor (TRIP) -3.3%. Downgraded at Cowen.
- VMware (VMW) -2.4%. Downgrade at Goldman Sachs.
- CSX (CSX) -2.3%. Downgraded at Stifel.